Radiotherapy and supportive care

Clinical Progress in Renal Cancer

Volumn , Issue , 2007, Pages 191-201

  Khoo, Vincent ^a   Pyle, Lynda ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84995808533     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (26)

1. Riches EW, Griffiths IH, Thackray AC. New growths of the kidney and ureter. Br J Urol 1951; 23(4): 297-356.
2. Flocks RH, Kadesky MC. Malignant neoplasms of the kidney; an analysis of 353 patients followed five years or more. J Urol 1958; 79(2): 196-201.
3. Bratherton DG. The place of radiotherapy in the treatment of hypernephroma. Br J Radiol 1969; 42(504): 949.
4. Peeling WB, Mantell BS, Shepheard BG. postoperative irradiation in the treatment of renal cell carcinoma. Br J Urol 1969; 41(1): 23-31.
5. Rafla S. Renal cell carcinoma. Natural history and results of treatment. Cancer 1970; 25(1): 26-40.
6. Stein M, Kuten A, Halpern J et al. The value of postoperative irradiation in renal cell cancer. Radiother Oncol 1992; 24(1): 41-4.
7. van der Werf-Messing B. Proceedings: carcinoma of the kidney. Cancer 1973; 32(5): 1056-61.
8. Juusela H, Malmio K, Alfthan O, Oravisto KJ. Preoperative irradiation in the treatment of renal adenocarcinoma. ScandJ Urol Nephrol 1977; 11(3): 277-81.
9. Finney R. The value of radiotherapy in the treatment of hypernephroma - a clinical trial. Br J Urol 1973; 45(3): 258-69.
10. Kjaer M, Iversen P, Hvidt V et al. A randomized trial of postoperative radiotherapy versus observation in stage II and III renal adenocarcinoma. A study by the Copenhagen Renal Cancer Study Group. Scand J Urol Nephrol 1987; 21(4): 285-9.
11. Kjaer M, Frederiksen PL, Engelholm SA. Postoperative radiotherapy in stage II and III renal adenocarcinoma. A randomized trial by the Copenhagen Renal Cancer Study Group. Int J Radiat Oncol Biol Phys 1987; 13(5): 665-72.
12. Bratherton DG. The place of radiotherapy in the treatment of hypernephroma. Br J Radiol 1969; 42: 949.
13. Sandeman TF. The radiotherapy of malignant disease of the kidney and ureter. Australas Radiol 1970; 14: 285-93.
14. Finney R. The value of radiotherapy in the treatment of hypernephroma - a clinical trial. Br J Urol. 1973; 45: 258-69.
15. Malkin RB. Regression of renal carcinoma following radiation therapy. J Urol. 1975; 114: 782-3.
16. Brady LW Jr. Carcinoma of the kidney - the role for radiation therapy. Semin Oncol 1983; 10: 417-21.
17. Beitler JJ, Makara D, Silverman P, Lederman G. Definitive, high-dose-per-fraction, conformal, stereotactic external radiation for renal cell carcinoma. Am J Clin Oncol 2004; 27(6): 646-8.
18. Emami B, Lyman J, Brown A et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991; 21(1): 109-22.
19. Halperin EC, Harisiadis L. The role of radiation therapy in the management of metastatic renal cell carcinoma. Cancer 1983; 51(4): 614-17.
20. Onufrey V, Mohiuddin M. Radiation therapy in the treatment of metastatic renal cell carcinoma. Int J Radiat Oncol Biol Phys 1985; 11(11): 2007-9.
21. Lee J, Hodgson D, Chow E et al. A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma. Cancer 2005; 104(9): 1894-900.
22. Mori Y, Kondziolka D, Flickinger JC, Logan T, Lunsford LD. Stereotactic radiosurgery for brain metastasis from renal cell carcinoma. Cancer 1998; 83(2): 344-53.
23. Van Spronsen DJ, Mulders PFA, De Mulder PHM. Novel treatments for metastatic renal carcinoma. Crit Rev Oncol Hematol 2005; 55: 177-91.
24. Robert CS, Soria J-C, Spatz A et al. Cutaneous side-effects of kinase inhibitors and blocking antibodies. Lancet Oncol 2005; 6: 491-500.
25. Manchen B. Nursing management of patients undergoing treatment for renal cell carcinoma. Advances in the treatment of renal carcinoma 2006.
26. Mrozek-Orlowski ME, Frye DK, Sanborn HM. Capecitabine: nursing implications of a new oral chemotherapy agent. Oncol Nurse Forum 1999; 26: 753-62.